Vischer advised Ikerian, a healthcare software platform company, on its first round of USD 8m Series B financing to advance its AI platform. The Series B financing round is led by strategic investor Sanoptis led
Lenz & Staehelin acted as Swiss counsel for GAM Holding, a publicly listed company on the SIX Swiss Exchange. GAM projected a capital increase and rights offering was completed as planned. Net proceeds from the
Walder Wyss successfully represented Freight Investor Services (FIS), a broker and service provider in freight and commodity derivatives, in various proceedings before the courts of Geneva and Lausanne. The counseling helped FIS to successfully recover
Homburger advised Alchemy US on the renewal of its credit financings. The firm entered into a term loan credit agreement with HPS Investment as a term loan agent. The firm also entered into an asset-based
Alexander Toller (pictured) has been appointed first-ever general counsel of Rolex. Starting on January 1, the former partner at Lalive for nearly three decades, will take care of the legal needs of the luxury watches brand
Borel & Barbey has advised artist Yoko Ono in her action to recover a Patek Philippe watch belonging to her late husband John Lennon. The rare watch, stolen in 2005, was a gift by Mrs. Ono
Bär & Karrer has acted as GBA Group’s legal advisor in the acquisition of a majority stake in Niutec. Bär & Karrer’s team In particular, Bär & Karrer acted with
Niederer Kraft Frey advised Georg Fischer (GF) on its agreement with United Grinding Group, a Swiss-based grinding technology company, to sell GF’s Machining Solutions Division. The transaction values the division between CHF 630 million and
On October 25, 2024, Homburger advised Molecular Partners, a clinical-stage biotechnology company, in the announcement of the pricing of an underwritten public offering. The offering consisted of 3,642,988 American Depositary Shares (ADSs), representing new shares, priced at $5.49 per
Homburger advised Elanco in Switzerland on any aspect of Swiss law within the transaction. The background On the 13th of August 2024, Elanco Animal Health and Elanco US entered into an incremental assumption agreement to obtain
